BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$3.58B |
| 2 |
Microsoft
MSFT
|
+$3.36B |
| 3 |
GE Vernova
GEV
|
+$2.86B |
| 4 |
CRH
CRH
|
+$2.57B |
| 5 |
Amazon
AMZN
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$4.23B |
| 2 |
GE Aerospace
GE
|
+$1.37B |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.23B |
| 4 |
Super Micro Computer
SMCI
|
+$1.17B |
| 5 |
AbbVie
ABBV
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.27% |
| 2 | Healthcare | 12.09% |
| 3 | Financials | 11.69% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDX
4326
Insight Molecular Diagnostics
IMDX
$150M
| $215K | ﹤0.01% |
72,827
+12,640
| +21% | +$34.7K |
|
4327
GSI Technology
GSIT
$215M
| $215K | ﹤0.01% |
81,061
+4,263
| +6% | +$13.9K |
|
4328
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
| $210K | ﹤0.01% |
+3,350
| New | +$195K |
|
4329
Vanguard Morningstar Mega Cap ETF
MGC
$9.99B
| $208K | ﹤0.01% |
+1,055
| New | +$198K |
|
|
NVNO
4330
enVVeno Medical
NVNO
$7.08M
| $207K | ﹤0.01% |
1,128
+57
| +5% | +$9.95K |
|
|
MTLS
4331
Materialise
MTLS
$368M
| $207K | ﹤0.01% |
41,335
-28,371
| -41% | -$146K |
|
4332
Playboy Inc
PLBY
$128M
| $204K | ﹤0.01% |
262,650
-111,752
| -30% | -$104K |
|
|
CBIO
4333
Crescent Biopharma
CBIO
$537M
| $204K | ﹤0.01% |
7,232
-94
| -1% | -$9.77K |
|
4334
loanDepot
LDI
$532M
| $202K | ﹤0.01% |
122,384
+2
| +0% | +$4 |
|
4335
TherapeuticsMD
TXMD
$23.5M
| $201K | ﹤0.01% |
125,152
-10,627
| -8% | -$21.5K |
|
|
NFGC
4336
New Found Gold
NFGC
$522M
| $201K | ﹤0.01% |
71,068
| – | – |
|
4337
Bolt Biotherapeutics
BOLT
$7.67M
| $200K | ﹤0.01% |
13,353
+605
| +5% | +$11.9K |
|
4338
SurgePays
SURG
$5.48M
| $199K | ﹤0.01% |
62,482
+12,046
| +24% | +$45.5K |
|
|
LVROW
4339
DELISTED
Lavoro Ltd Warrant
LVROW
| $198K | ﹤0.01% |
494,750
-716
| -0.1% | -$288 |
|
|
BINI
4340
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
4341
Crexendo
CXDO
$223M
| $196K | ﹤0.01% |
62,452
+1,539
| +3% | +$5.99K |
|
4342
Benitec Biopharma
BNTC
$402M
| $196K | ﹤0.01% |
+28,004
| New | +$207K |
|
4343
First National Corp
FXNC
$287M
| $195K | ﹤0.01% |
12,838
+542
| +4% | +$8.34K |
|
4344
First Guaranty Bancshares
FGBI
$159M
| $195K | ﹤0.01% |
21,655
+656
| +3% | +$6.75K |
|
4345
Lisata Therapeutics
LSTA
$9.02M
| $194K | ﹤0.01% |
56,013
| – | – |
|
4346
Camtek
CAMT
$6.18B
| $193K | ﹤0.01% |
1,544
+923
| +149% | +$88.1K |
|
|
TVRD
4347
Tvardi Therapeutics
TVRD
$19.7M
| $192K | ﹤0.01% |
20,686
-74,352
| -78% | -$1.77M |
|
4348
a.k.a. Brands
AKA
$124M
| $190K | ﹤0.01% |
12,433
+11,169
| +884% | +$178K |
|
|
PPSI
4349
Pioneer Power Solutions
PPSI
$32.3M
| $189K | ﹤0.01% |
47,685
+1,330
| +3% | +$5.3K |
|
|
ADAP
4350
DELISTED
Adaptimmune Therapeutics
ADAP
| $189K | ﹤0.01% |
193,757
-95,931
| -33% | -$105K |
|
Similar funds
BlackRock's Q2 2024 Portfolio in Review
As of Q2 2024, BlackRock held 5,453 positions worth $4.42T, up 2.9% from $4.3T the previous quarter. Its ten largest holdings account for 27% of the portfolio.
BlackRock's Q2 2024 filing shows 174 new, 2,441 increased, 2,110 reduced and 172 closed positions. Its largest new stake was Solventum: 11,038,924 shares worth $584M. The largest sale was Pioneer Natural Resource Co., an estimated $4.23B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2024 buy was Solventum: 11,038,924 shares worth $584M.
- BlackRock added most to ExxonMobil in Q2 2024, an estimated $3.58B increase.
- BlackRock's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $1.37B.
- BlackRock fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $4.23B.
- BlackRock's ten largest holdings make up 27% of its $4.42T portfolio in Q2 2024.
- BlackRock opened 174 new positions and closed 172 in Q2 2024.
- BlackRock's portfolio value rose 2.9% quarter-over-quarter to $4.42T.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.